Literature DB >> 30067064

Time Required to Achieve Minimal Clinically Important Difference and Substantial Clinical Benefit After Arthroscopic Treatment of Femoroacetabular Impingement.

Benedict U Nwachukwu1, Brenda Chang1, Joshua Adjei1, William W Schairer1, Anil S Ranawat1, Bryan T Kelly1, Danyal H Nawabi1.   

Abstract

BACKGROUND: Minimal clinically important difference (MCID) defines the minimum degree of quantifiable outcome improvement that a patient perceives as the result of an intervention or in the process of healing. Substantial clinical benefit (SCB) defines the amount of quantifiable outcome improvement that is needed for a patient to feel substantially better. Little is known about when clinically significant outcome improvement is achieved.
PURPOSE: To investigate the time-dependent nature of MCID and SCB after hip arthroscopy for femoroacetabular impingement (FAI). STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: An institutional hip preservation registry was queried. The modified Harris Hip Score, Hip Outcome Score, and 33-item International Hip Outcome Tool (iHOT-33) were administered to patients undergoing hip arthroscopy for FAI. Follow-up times for outcome measures were classified into 3 periods: 5 to 11 months (6 months), 12 to 23 months (1 year), and 24 to 35 months (2 years). Cumulative probabilities for achieving MCID and SCB were calculated with Kaplan-Meier survival curve analysis and interval censoring. A Weibull parametric regression analysis evaluated the odds of achieving earlier MCID.
RESULTS: A total of 719 patients undergoing primary hip arthroscopy were included. The mean ± SD age was 32.5 ± 10.5 years, and the majority were female (n = 380, 52.9%). Across all 4 outcome instruments, patients had the highest probability for achieving MCID and SCB by the 6-month postoperative period. The iHOT-33 demonstrated the highest probability for capturing MCID and SCB improvement at each of the 3 periods, with 76.0%, 84.8%, and 93.6% achieving MCID by 6 months, 1 year, and 2 years, respectively. Similarly, the probabilities of achieving SCB on the iHOT-33 were as follows: 57.1%, 68.0%, and 71.7%. A similar trend was demonstrated across other outcome tools. Older male patients and those with Outerbridge classification 1 to 4 (vs grade 0) had a significantly increased risk for taking a longer time to achieve MCID and SCB. Additionally, patients with higher preoperative outcome scores took a longer time to achieve MCID and SCB.
CONCLUSION: At least half of patients treated with hip arthroscopy for FAI achieve MCID and SCB within the first 6 months after the procedure. However, clinically significant outcome improvement continues to be attained until 2 years postoperatively. Female patients, younger individuals, and those without chondral defects achieve faster clinical outcome improvement. These findings can be helpful for establishing shared decision-making aids and follow-up guidelines for arthroscopic treatment of FAI.

Entities:  

Keywords:  epidemiology; femoroacetabular impingement; hip arthroscopy; minimal clinically important difference; outcome; quality of life; substantial clinical benefit

Mesh:

Year:  2018        PMID: 30067064     DOI: 10.1177/0363546518786480

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  27 in total

1.  Hip arthroscopy with initial access to the peripheral compartment provides significant improvement in FAI patients.

Authors:  Pedro Dantas; Sérgio Gonçalves; Vasco Mascarenhas; Antonio Camporese; Oliver Marin-Peña
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-01-02       Impact factor: 4.342

2.  Violation of expectations is correlated with satisfaction following hip arthroscopy.

Authors:  Shai Factor; Yair Neuman; Matias Vidra; Moshe Shalom; Adi Lichtenstein; Eyal Amar; Ehud Rath
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-10-01       Impact factor: 4.114

3.  The Effect of State-Level Prescription Opioid Legislation on Patient Outcomes After Lumbar Tubular Microdecompression.

Authors:  Edward C Beck; Jonathan C White; Anirudh K Gowd; Tianyi D Luo; Carl Edge; Ziyad O Knio; Tadhg J O'Gara
Journal:  Int J Spine Surg       Date:  2022-06-16

4.  What the papers say.

Authors:  Ajay Malviya
Journal:  J Hip Preserv Surg       Date:  2018-10-30

5.  Hip Arthroscopy: A Social Media Analysis of Patient Perception.

Authors:  Heather S Haeberle; Nicholas I Bartschat; Sergio M Navarro; Patrick W Rooney; James Rosneck; Robert W Westermann; Prem N Ramkumar
Journal:  Orthop J Sports Med       Date:  2019-06-18

6.  A tiered system using substantial clinical benefit and patient acceptable symptomatic state scores to evaluate 2-year outcomes of hip arthroscopy with the Hip Outcome Score.

Authors:  RobRoy L Martin; Benjamin R Kivlan; John J Christoforetti; Andrew B Wolff; Shane J Nho; John P Salvo; Geoff Van Thiel; Dean Matsuda; Dominic S Carreira
Journal:  J Hip Preserv Surg       Date:  2020-02-03

7.  Preoperative Performance of the PROMIS in Patients Undergoing Hip Arthroscopic Surgery for Femoroacetabular Impingement Syndrome.

Authors:  Benedict U Nwachukwu; Edward C Beck; Reagan Chapman; Jorge Chahla; Kelechi Okoroha; Shane J Nho
Journal:  Orthop J Sports Med       Date:  2019-07-29

8.  Effect of prior ipsilateral lower extremity surgery on 2-year outcomes following hip arthroscopy for femoroacetabular impingement syndrome.

Authors:  Kyle N Kunze; Edward C Beck; Kelechi R Okoroha; Jorge Chahla; Sunikom Suppauksorn; Charles A Bush-Joseph; Akhil Katakam; Shane J Nho
Journal:  J Hip Preserv Surg       Date:  2019-07-20

9.  What is the Role of Kinesiophobia and Pain Catastrophizing in Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome?

Authors:  Ian M Clapp; Benedict U Nwachukwu; Edward C Beck; Jonathan P Rasio; Thomas Alter; Bradley Allison; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-01-08

Review 10.  Cost-Effectiveness of Hip Arthroscopy for Treatment of Femoroacetabular Impingement Syndrome and Labral Tears: A Systematic Review.

Authors:  Cammille C Go; Cynthia Kyin; Jeffrey W Chen; Benjamin G Domb; David R Maldonado
Journal:  Orthop J Sports Med       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.